Cas no 298693-03-5 (Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)-)

Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)- structure
298693-03-5 structure
Product Name:Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)-
CAS No:298693-03-5
MF:C19H32N2O2
MW:320.469585418701
MDL:MFCD32201206
CID:4464084
PubChem ID:10639448
Update Time:2025-07-14

Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)- Chemical and Physical Properties

Names and Identifiers

    • Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)-
    • (4S,4'S)-2,2'-Cyclopentylidenebis[4-tert-butyl-4,5-dihydro oxazole],99%e.e.
    • (4S,4'S)-2,2'-Cyclopentylidenebis[4-tert-butyl-4,5-dihydrooxazole]
    • (4S,4'S)-2,2'-Cyclopentylidenebis[4-tert-butyl-4,5-dihydrooxazole], 95%, (99% ee)
    • (4S,4'S)-2,2'-(Cyclopentane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole)
    • AKOS037651188
    • CS-16085
    • 298693-03-5
    • YLA69303
    • (4S)-4-tert-butyl-2-[1-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]cyclopentyl]-4,5-dihydro-1,3-oxazole
    • SCHEMBL25860683
    • CS-0087865
    • MFCD32201206
    • D74658
    • (4S,4''S)-2,2''-Cyclopentylidenebis[4-tert-butyl-4,5-dihydrooxazole]
    • MDL: MFCD32201206
    • Inchi: 1S/C19H32N2O2/c1-17(2,3)13-11-22-15(20-13)19(9-7-8-10-19)16-21-14(12-23-16)18(4,5)6/h13-14H,7-12H2,1-6H3/t13-,14-/m1/s1
    • InChI Key: WGMVBTAYSGCATC-ZIAGYGMSSA-N
    • SMILES: O1C[C@H](C(C)(C)C)N=C1C1(C2=N[C@H](CO2)C(C)(C)C)CCCC1

Computed Properties

  • Exact Mass: 320.246378268g/mol
  • Monoisotopic Mass: 320.246378268g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 4
  • Heavy Atom Count: 23
  • Rotatable Bond Count: 4
  • Complexity: 475
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 2
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 4.5
  • Topological Polar Surface Area: 43.2?2

Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)- Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-ER084-200mg
Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)-
298693-03-5 97%
200mg
1037.0CNY 2021-07-17
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-ER084-50mg
Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)-
298693-03-5 97%
50mg
323.0CNY 2021-07-17
SU ZHOU XIN JIA YUAN HUA XUE Technology Co., Ltd.
lj1417-100mg
Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)-
298693-03-5 95%,99%ee
100mg
¥990.0 2024-07-19
SU ZHOU XIN JIA YUAN HUA XUE Technology Co., Ltd.
lj1417-50mg
Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)-
298693-03-5 95%,99%ee
50mg
¥595.0 2024-07-19
SU ZHOU XIN JIA YUAN HUA XUE Technology Co., Ltd.
lj1416-100mg
Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)-
298693-03-5 98%,99%ee
100mg
1404CNY 2021-05-07
SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd.
S81580-100mg
(4S,?4'S)?-2,?2'-Cyclopentylidenebis[?4-?tert-butyl?-?4,?5-?dihydrooxazole]
298693-03-5 97%
100mg
¥429.0 2024-07-19
SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd.
S81580-250mg
(4S,?4'S)?-2,?2'-Cyclopentylidenebis[?4-?tert-butyl?-?4,?5-?dihydrooxazole]
298693-03-5 97%
250mg
¥880.0 2024-07-19
SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd.
S81580-1g
(4S,?4'S)?-2,?2'-Cyclopentylidenebis[?4-?tert-butyl?-?4,?5-?dihydrooxazole]
298693-03-5
1g
¥3456.0 2021-09-04
abcr
AB541727-50 mg
(4S,4'S)-2,2'-Cyclopentylidenebis[4-tert-butyl-4,5-dihydrooxazole], 95%, (99% ee); .
298693-03-5 95%
50mg
€151.00 2023-07-10
SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd.
S81580-100mg
(4S,?4'S)?-2,?2'-Cyclopentylidenebis[?4-?tert-butyl?-?4,?5-?dihydrooxazole]
298693-03-5 97%
100mg
¥429.0 2023-09-09

Additional information on Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)-

Comprehensive Overview of Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)- (CAS No. 298693-03-5)

The compound Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)- (CAS No. 298693-03-5) is a specialized organic molecule with a unique structural framework. Its oxazole core, combined with cyclopentylidene and tert-butyl groups, makes it a subject of interest in pharmaceutical and material science research. This compound's stereochemistry, denoted by (4S,4'S)-, further enhances its potential for chiral applications, aligning with the growing demand for enantioselective synthesis in modern chemistry.

In recent years, the scientific community has shown increasing interest in oxazole derivatives due to their versatile biological activities and applications in drug discovery. The 2,2'-cyclopentylidenebis moiety in this compound introduces rigidity to the molecular structure, which can be leveraged for designing novel catalysts or ligands. Researchers are particularly intrigued by its potential role in asymmetric synthesis, a hot topic in organic chemistry, as it addresses the need for efficient and sustainable chiral building blocks.

The tert-butyl groups in this compound contribute to its steric hindrance, a property highly valued in the development of high-performance materials. This aligns with current trends in nanotechnology and polymer science, where bulky substituents are often used to tune material properties. Additionally, the dihydro-oxazole segment offers opportunities for further functionalization, making it a versatile intermediate in synthetic chemistry.

From an industrial perspective, CAS No. 298693-03-5 is gaining attention for its potential in green chemistry initiatives. Its structural features may enable cleaner synthetic routes, reducing waste and energy consumption—a priority for sustainable manufacturing. This resonates with global efforts to adopt eco-friendly chemical processes, a frequently searched topic among researchers and policymakers.

Analytical techniques such as NMR spectroscopy and X-ray crystallography are essential for characterizing this compound's purity and stereochemistry. These methods are widely discussed in academic circles, as accurate structural elucidation is critical for reproducibility in research. The compound's chiral centers also make it a candidate for studies in molecular recognition, a field with applications ranging from drug design to sensor development.

In summary, Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)- represents a multifaceted compound with promising applications across multiple disciplines. Its combination of steric bulk, chirality, and functional versatility positions it as a valuable asset in both academic and industrial settings, addressing contemporary challenges in chemistry and materials science.

Recommended suppliers
Nanjing Jubai Biopharm
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Nanjing Jubai Biopharm
Jiangxi Boyang Pharmaceutical Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jiangxi Boyang Pharmaceutical Chemical Co., Ltd
上海帛亦醫(yī)藥科技有限公司
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Henan Dongyan Pharmaceutical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Henan Dongyan Pharmaceutical Co., Ltd